A5062225091- Opioid Use Disorder Treatment
- Substance Abuse Treatment and Outcomes
- Pain Management and Opioid Use
- Pharmaceutical Practices and Patient Outcomes
- Prenatal Substance Exposure Effects
- Poisoning and overdose treatments
- Cannabis and Cannabinoid Research
- HIV, Drug Use, Sexual Risk
- Bipolar Disorder and Treatment
- Anesthesia and Pain Management
- Musculoskeletal pain and rehabilitation
- Pediatric Pain Management Techniques
- Mental Health Treatment and Access
- Intensive Care Unit Cognitive Disorders
- Health Policy Implementation Science
- Homelessness and Social Issues
- Pharmacological Effects and Toxicity Studies
- Emergency and Acute Care Studies
- Blood Pressure and Hypertension Studies
- Healthcare professionals’ stress and burnout
- Maternal Mental Health During Pregnancy and Postpartum
- Hospital Admissions and Outcomes
- Healthcare Decision-Making and Restraints
- Antibiotic Use and Resistance
- Forensic Toxicology and Drug Analysis
University of Colorado Hospital
2019-2025
University of Colorado Denver
2016-2025
Outcomes Research Consortium
2022-2024
University of Colorado Anschutz Medical Campus
2017-2024
Children's Hospital Colorado
2023
Smithsonian Latino Center
2020-2021
Denver Health Medical Center
2012-2020
Health and Hospital Corporation
2018-2019
Ontario Institute for Cancer Research
2017
University Hospitals Birmingham NHS Foundation Trust
2017
Objective. There is inadequate evidence of long-term benefit and growing the risks chronic opioid therapy (COT). Opioid dose reduction, or tapering, may reduce these but also worsen pain quality life. Our objective was to explore patients’ perspectives on tapering. Design. Qualitative study using in-person, semistructured interviews. Setting Patients. English-speaking, adult primary care patients (N = 24) in three Colorado health systems. Methods. Interviews were audio recorded, transcribed,...
Given the risks of long-term opioid therapy, patients may benefit from tapering these medications. There is little evidence to guide providers' approach this process. We explored primary care experiences discussing and implementing with on therapy.Qualitative study using six semistructured, in-person focus groups.Primary providers (N = 40).Six academically affiliated clinics in university, urban safety net, Veterans Health Administration medical centers Colorado.Focus groups were...
Study Objective Buprenorphine, a partial μ‐opioid agonist, is an effective treatment for opioid use disorder that conventionally requires symptoms of withdrawal before initiation to avoid precipitating withdrawal. Our institution implemented microdosing approach transition patients from full agonists buprenorphine without requiring undergo period abstinence. Little has been published about this strategy in the inpatient setting United States, and even less dealing with methadone...
Hospital‐based clinicians frequently treat acute, noncancer pain. Although opioids may be beneficial in this setting, the benefits must balanced with risks of adverse events, including inadvertent overdose and prolonged opioid use, physical dependence, or development use disorder. In an era epidemic related harms, Society Hospital Medicine (SHM) convened a working group to develop consensus statement on for adults hospitalized pain, outside palliative, end‐of‐life, intensive care settings....
OBJECTIVE For most common infections requiring hospitalization, antibiotic treatment is completed after hospital discharge. Postdischarge therapy often unnecessarily broad spectrum and prolonged. We developed an intervention to improve selection shorten durations. DESIGN Single center, quasi-experimental retrospective cohort study METHODS Patients prescribed oral antibiotics at discharge before (July 2012–June 2013) (October 2014–February 2015) consisting of (1) institutional guidance for...
Importance US primary care practitioners (PCPs) are the largest clinical workforce, but few provide addiction care. Primary is a practical place to expand services, including buprenorphine and harm reduction kits, yet outcomes health sector costs unknown. Objective To estimate long-term outcomes, costs, cost-effectiveness of integrated kits in for people who inject opioids. Design, Setting, Participants In this modeling study, Reducing Infections Related Drug Use Cost-Effectiveness (REDUCE)...
Background: Alcohol, tobacco, and other drugs are leading contributors of preventable U.S. deaths (1, 2). Hospitalizations provide opportunities for substance use disorder (SUD) treatment engagement patients who may not receive in settings have high rates health care utilization (3).Objective: To describe the prevalence hospitalizations among adults with SUD to inform potential impact hospital-based programs.Methods: We used 2022 National Survey on Drug Use Health survey identify...
Background Hospitalizations for complications related to opioid use disorder (OUD) are increasing. Hospitalists care most hospitalized patients in the United States, yet little is known about their attitudes, beliefs, and clinical practices regarding OUD-related care. Methods We distributed an online survey hospitalists States measure how access addiction specialists affected attitudes beliefs hospital-based OUD care, screening practices, naloxone prescribing, buprenorphine initiation....
Background: In response to the opioid epidemic, addiction consultation services (ACS) increasingly provide dedicated hospital-based treatment patients with substance use disorder. We assessed hospitalist and medical staff perceptions of how presence 2 hospitals' ACS impacted care for hospitalized disorder (OUD). inquired about ongoing challenges in caring this patient population.Methods: conducted a qualitative study providers utilizing focus groups key informant interviews data collection....